Cellular diagnostic patch test for immune protection against sars-cov-2 virus infection

The invention relates to the application of a skin patch test for the detection of the specific cellular immune response against the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2). The skin patch contains a formulated version of the recombinant form of SARS-CoV-2 antigenic protein. The...

Full description

Saved in:
Bibliographic Details
Main Authors Dr. Sarkadi Balazs, Dr. Buzas Edit, Dr. Moldvay Judit, Dr. Falus Andras, Mozner Orsolya
Format Patent
LanguageEnglish
Hungarian
Published 28.04.2022
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the application of a skin patch test for the detection of the specific cellular immune response against the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2). The skin patch contains a formulated version of the recombinant form of SARS-CoV-2 antigenic protein. The application of the skin patch allows to follow the local skin reaction reflecting the strength of the cellular immune reaction against SARS-CoV-2, thus the skin test is applicable to a diagnostic evaluation of the specific cellular immunity evoked by previous virus infection or by vaccination against COVID-19.
Bibliography:Application Number: HUP2000309